Who makes compounded sermorelin
By Ray Kaminski, who covers specialty pharmacy pricing and compounding economics.
Updated September 2026.
There is no approved sermorelin product on an American shelf, so every vial sold on this roster was made to order by a compounding pharmacy. Which one is the question a buyer would reasonably want answered, and it is the question this market has decided not to answer.
How far a seller goes varies: a pharmacy in the abstract, a section of the Act, a certification seal, a panel of test results — or, once, a name.
Narrow this board
Showing all 4 sellers.
90/100 discloses
Liberty
$116
a standing rateper month
200–500 mcg nightly, by phase
60/100 discloses
HelloWellness
$349
a total, paid up frontevery 11 weeks
dose not stated
55/100 discloses
System Labs
$109
an introductory pricefirst month
monthly supply, 9 mg
35/100 discloses
Luvo Health
$27
a floor, not a rateper week
dose not stated
Sellers that pay us a commission come first in their group, and their button says so. That position is the only thing paying us buys. Below it, each group is ordered by what each seller states about its own figure: the kind of price first, then the figure itself. The price, the dose, the score and the review read the same either way. This is a short list on a page about something else; the full board is on compare sermorelin sellers. Every figure above was read from the seller’s own page in September 2026. None of these 4 sellers names the pharmacy that compounds its sermorelin. A pharmacy named on a seller’s GLP-1 pages does not count: it says nothing about who makes this drug.
One seller of eighty-nine says who makes it
Compounded sermorelin is prepared by a pharmacy. That is not a detail; it is the whole manufacturing story, because there is no approved finished product behind it and the pharmacy is where the quality question actually lives. Of the 89 companies on this board, 1 names the pharmacy that compounds its sermorelin. 88 do not.
Roster rows naming the pharmacy that compounds their sermorelin
1 of 89 — drug-scoped
Seller pages we read invoking a pharmacy in any general terms
48 of 88
Seller pages we read saying the words “compounding pharmacy”
28 of 88
Seller pages we read citing section 503 of the Act
17 of 88
The first row counts the 89 companies on the board, read from each seller’s own sermorelin page: a pharmacy named on the same company’s weight-loss page does not count for sermorelin. The lower three rows count the 88 sermorelin pages we read in September 2026. The two numbers are different because the objects are; the note below sets them side by side.
The gap between the first row and the second is the finding. 48 of 88 pages tell you a pharmacy is involved — “our licensed partner pharmacy”, “a 503A compounding pharmacy”, “US-based pharmacies” — and 40 do not raise the subject at all. Almost none of the 48 turns that into a name you could look up.
Sermorelin Acetate Olympia Injection
That is VigorMeds, and the name is in the product title rather than in a paragraph about sourcing — which is how most disclosures of this kind survive on a sales page at all. It is the whole of it: one company, one pharmacy name, on a roster of 89 selling a drug whose only existence in the United States is as a compounded preparation.
Where these counts come from
Every “N of 88” on this page counts the 88 sermorelin seller pages we could read, in September 2026. The board lists 89 companies: the extra one publishes no sermorelin page we could read, so it is on the board and in none of these counts.
We counted what a seller printed where a buyer can see it, in September 2026. A price or an answer behind an intake form or a closed FAQ is not counted, which is why a count of 88 is a count of what these pages publish rather than of what these companies would tell you if you asked.
A seal is not a name
15 of the 88 seller pages we read carry a LegitScript mark, usually in a badge row beside free shipping and HIPAA compliance. It is worth being precise about what that answers. LegitScript certifies the merchant — the business taking your money — and a certification of the merchant is not an identification of the pharmacy, not a statement about the batch in the vial, and not a test result.
Six pages print a test panel, and every mark reads passed
6 of the 88 pages go further and publish a laboratory panel: potency, sterility, pH and endotoxins, the four together on one page. They are bmiMD, HealthOn, Invigor Medical, Ivy Rx, RxION Health, RxSaludable. On all 6, every one of the four is marked passed or approved.
Captured sermorelin pages, out of the 88 we read
Counted over the 88 sermorelin pages we read in September 2026. The last row is the 6 pages printing all four test results together. The 1-of-89 pharmacy figure is left off this chart on purpose: it counts companies on the board rather than pages, and the two do not belong on one scale.
What is odd about the 6 test panels
Three of the 6 print a tolerance beside the test — “± 10 % of target strength” — which is the specification the test is measured against and not the result of measuring anything. Invigor Medical is the only one of the 6 that prints a date beside each test, and every date on it reads 01-01-01. We have not established what those dates mean and we are not going to guess; we record that a reader cannot date the panel.
None of the 6 identifies the laboratory, and none identifies the pharmacy whose product was tested — which is the same gap as the rest of this page, one layer further in. A result with no lab, no date you can read and no named subject is a reassurance rather than a record.
What “FDA-approved” is doing on these pages
There is no FDA-approved sermorelin product marketed in the United States. The last approved one, Geref, was discontinued in 2008, and both its approvals were withdrawn in 2009 (Federal Register, 2013). Everything on this roster is therefore a compounded preparation, and of those the FDA says: “Compounded drugs are not FDA-approved. This means that FDA does not verify the safety, effectiveness or quality of compounded drugs before they are marketed.” (FDA, Compounding Q&A).
36 of the 88 seller pages we read say so somewhere on them, which is the majority and is to their credit. But the phrase itself appears far more widely than that: 46 of 88 print “FDA-approved” in some construction, and 11 of those print it with no not-FDA-approved sentence anywhere on the page.
46 of 88
Print the phrase at all
36 of 88
Say what they sell is not FDA-approved
11 of 88
Print it with no such sentence anywhere
1 of 89
Name the pharmacy that compounds their sermorelin
We read all 11, and they are doing four different things. Two use the phrase accurately, about Geref’s discontinuation. Three carry it only inside a collapsed FAQ question, so it is in the document but not on the page as it renders. Four use it in a trademark disclaimer about a weight-loss drug that has nothing to do with sermorelin. And three attach it to something the agency does not approve at all — an “FDA-approved pharmacy”, labs described as “FDA approved”, and a badge reading “FDA-Approved Compounds” in a row with free shipping.
Those four groups do not add up to 11, and that is not an arithmetic slip: Get Thin MD is in two of them, using the phrase correctly in one place and inside a shut FAQ panel in another. We are describing what the phrase is doing rather than sorting the pages into boxes, and a page can do two things at once.
Questions
Who actually compounds sermorelin for these sellers?
On this evidence, we cannot tell you for 88 of the 89 companies on this board, because their own pages do not say. VigorMeds names one. What the rest publish is a category — a licensed pharmacy, a 503A pharmacy, a partner pharmacy — and a category is not an identity you can check.
Does a LegitScript seal tell me the pharmacy is good?
It does not answer that question. LegitScript certifies the merchant taking the payment. 15 of the 88 pages we read carry the mark, and none of them uses it to name a pharmacy. Treat it as a statement about the business you are buying from, which is a real thing to know and a different thing.
What is a 503A pharmacy?
It is the section of the Food, Drug and Cosmetic Act that compounding for an individual patient is done under, so “503A pharmacy” describes a class of pharmacy rather than a particular one. 17 of the 88 seller pages we read cite the section. On these pages the citation almost never arrives with a pharmacy name attached, which is what makes it a reassurance rather than a disclosure.
Are the published test results reliable?
We are not in a position to say, and neither is a reader, which is the point. 6 of 88 pages publish a four-test panel; on all 6 every mark reads passed, none identifies the laboratory, none identifies the pharmacy whose product was tested, and the one page that dates its tests dates all of them 01-01-01.
Has any of this changed recently?
We hold no evidence either way. Every seller here was read once, on one day. This site holds 1 reading per seller and no second reading of anything, so nothing on it describes a price moving, a term changing, or a seller adding a disclosure since we last looked. What it can say is what was published on the day it was read, counted across the whole roster.
Who decides you can have sermorelin What else these sellers are selling Sermorelin side effects